U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. It was current when produced, but is no longer maintained and may - Gadoteridol - Document - PDFSEARCH.IO

First Page	Meta Content
	U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. It was current when produced, but is no longer maintained and may Add to Reading List Open Document File Size: 249,88 KB Share Result on Facebook City Gadolinium / / Company Ligand / M.D. Bracco Diagnostics Inc. / HP / / Country United Kingdom / United States / / Event FDA Phase / / IndustryTerm contrast media / pharmaceutical ingredient / magnetic resonance imaging / chemical structure / paramagnetic contrast media / / Organization National Science Foundation / U.S. Food and Drug Administration / / Person Gaithersburg / / Product Magnevist / Omniscan / ProHance / MultiHance / OptiMARK / ProHance® (gadoteridol) injection / / Technology magnetic resonance imaging / MRI / / SocialTag Nephrology Gadodiamide Gadolinium Magnetic resonance imaging Gadoteridol Gadopentetic acid Renal failure MRI contrast agent Nephrogenic systemic fibrosis Chemistry

U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. It was current when produced, but is no longer maintained and may Add to Reading List